{
  "analysis_mode": "HISTORICAL_ONLY",
  "symbol": "POLX.L",
  "generated_at": "2026-02-09T07:51:50.770016Z",
  "top_card": {
    "ticker": "POLX.L",
    "company_name": "Polarean Imaging plc",
    "sector": "Healthcare",
    "market_cap_gbp": 965626,
    "days_active": 25,
    "apex_score_100": 52,
    "confidence_score_100": 40,
    "ai_final_score_25": 13,
    "ai_strength": "MODERATE",
    "timing_regime": "TOO_EARLY",
    "action": "WATCH",
    "thesis_one_liner": "WATCH - TOO_EARLY timing with 52/100 opportunity score"
  },
  "enrichment": {
    "company_info": {
      "name": "Polarean Imaging plc",
      "sector": "Healthcare",
      "industry": "Medical Devices",
      "exchange": "LSE",
      "market": "AIM",
      "currency": "GBP",
      "risk_tier": "High Risk",
      "current_market_cap": 965626,
      "current_close_price": 0.08
    },
    "basics": {
      "ticker": "POLX.L",
      "current_price": 0.08,
      "ath": 113.0,
      "atl": 0.06,
      "ath_date": "2021-09-27",
      "atl_date": "2025-12-22",
      "week_52_high": 1.6,
      "week_52_low": 0.06,
      "week_52_high_date": "2025-02-12",
      "week_52_low_date": "2025-12-22",
      "drawdown_from_ath_pct": 99.93,
      "data_start": "2020-01-02",
      "data_end": "2025-12-22",
      "total_bars": 1510
    },
    "latest_signal": {
      "date": "2025-11-27",
      "scan_date": "2026-01-26",
      "signal_type": "DEEP CRASH BOTTOM",
      "signal_color": "GREEN",
      "price": 0.08,
      "drawdown_pct": 95.0,
      "ai_score": 11.0,
      "rsi": 10.5,
      "cycle_position": 0.0282,
      "holding_period_days": 25,
      "current_pnl_pct": -0.0,
      "rally_state": "accumulating",
      "distance_from_high_pct": -62.79,
      "Rally_Count": 2,
      "days_since_last_high": 48,
      "last_high_date": "2025-12-09",
      "lock_in_reached": true,
      "lock_in_date": "2025-12-08",
      "best_rally_pct": 168.75
    },
    "best_historical_signal": {
      "signal_date": "2025-11-24",
      "signal_type": "EXTREME CRASH BOTTOM",
      "signal_color": "ORANGE",
      "entry_price": 0.08,
      "peak_price": 0.24,
      "peak_date": "2025-12-09",
      "rally_pct": 200.0,
      "days_to_peak": 15,
      "ai_score": 13.0
    },
    "all_historical_signals": [
      {
        "signal_id": "POLX.L_2023-08-02",
        "signal_date": "2023-08-02",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 16.5,
        "current_price": 0.08,
        "current_return_pct": -99.52,
        "best_rally_pct": 12.12,
        "best_rally_date": "2023-08-07",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -99.57,
        "days_since_last_high": 48,
        "lock_in_reached": true,
        "age_days": 908,
        "status": "historical"
      },
      {
        "signal_id": "POLX.L_2023-08-03",
        "signal_date": "2023-08-03",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 15.8,
        "current_price": 0.08,
        "current_return_pct": -99.49,
        "best_rally_pct": 17.09,
        "best_rally_date": "2023-08-07",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -99.57,
        "days_since_last_high": 48,
        "lock_in_reached": true,
        "age_days": 907,
        "status": "historical"
      },
      {
        "signal_id": "POLX.L_2023-08-09",
        "signal_date": "2023-08-09",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 15.75,
        "current_price": 0.08,
        "current_return_pct": -99.49,
        "best_rally_pct": -1.59,
        "best_rally_date": "2023-08-10",
        "rally_state": "accumulating",
        "Rally_Count": 0,
        "distance_from_high_pct": 0.0,
        "days_since_last_high": 48,
        "lock_in_reached": true,
        "age_days": 901,
        "status": "historical"
      },
      {
        "signal_id": "POLX.L_2023-08-10",
        "signal_date": "2023-08-10",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 15.5,
        "current_price": 0.08,
        "current_return_pct": -99.48,
        "best_rally_pct": -1.61,
        "best_rally_date": "2023-08-11",
        "rally_state": "accumulating",
        "Rally_Count": 0,
        "distance_from_high_pct": 0.0,
        "days_since_last_high": 48,
        "lock_in_reached": true,
        "age_days": 900,
        "status": "historical"
      },
      {
        "signal_id": "POLX.L_2023-08-16",
        "signal_date": "2023-08-16",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 14.25,
        "current_price": 0.08,
        "current_return_pct": -99.44,
        "best_rally_pct": 7.02,
        "best_rally_date": "2023-08-25",
        "rally_state": "accumulating",
        "Rally_Count": 0,
        "distance_from_high_pct": -99.48,
        "days_since_last_high": 48,
        "lock_in_reached": true,
        "age_days": 894,
        "status": "historical"
      },
      {
        "signal_id": "POLX.L_2023-09-07",
        "signal_date": "2023-09-07",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 11.5,
        "current_price": 0.08,
        "current_return_pct": -99.3,
        "best_rally_pct": 0.0,
        "best_rally_date": "2023-09-08",
        "rally_state": "accumulating",
        "Rally_Count": 0,
        "distance_from_high_pct": 0.0,
        "days_since_last_high": 48,
        "lock_in_reached": true,
        "age_days": 872,
        "status": "historical"
      },
      {
        "signal_id": "POLX.L_2023-09-13",
        "signal_date": "2023-09-13",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 10.75,
        "current_price": 0.08,
        "current_return_pct": -99.26,
        "best_rally_pct": -3.49,
        "best_rally_date": "2023-09-22",
        "rally_state": "accumulating",
        "Rally_Count": 0,
        "distance_from_high_pct": 0.0,
        "days_since_last_high": 48,
        "lock_in_reached": true,
        "age_days": 866,
        "status": "historical"
      },
      {
        "signal_id": "POLX.L_2023-09-14",
        "signal_date": "2023-09-14",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 9.25,
        "current_price": 0.08,
        "current_return_pct": -99.14,
        "best_rally_pct": 12.16,
        "best_rally_date": "2023-09-22",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -99.23,
        "days_since_last_high": 48,
        "lock_in_reached": true,
        "age_days": 865,
        "status": "historical"
      },
      {
        "signal_id": "POLX.L_2023-09-15",
        "signal_date": "2023-09-15",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 10.0,
        "current_price": 0.08,
        "current_return_pct": -99.2,
        "best_rally_pct": 3.75,
        "best_rally_date": "2023-09-22",
        "rally_state": "accumulating",
        "Rally_Count": 0,
        "distance_from_high_pct": -99.23,
        "days_since_last_high": 48,
        "lock_in_reached": true,
        "age_days": 864,
        "status": "historical"
      },
      {
        "signal_id": "POLX.L_2023-09-22",
        "signal_date": "2023-09-22",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 10.375,
        "current_price": 0.08,
        "current_return_pct": -99.23,
        "best_rally_pct": -2.17,
        "best_rally_date": "2023-09-26",
        "rally_state": "accumulating",
        "Rally_Count": 0,
        "distance_from_high_pct": 0.0,
        "days_since_last_high": 48,
        "lock_in_reached": true,
        "age_days": 857,
        "status": "historical"
      },
      {
        "signal_id": "POLX.L_2023-10-02",
        "signal_date": "2023-10-02",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 9.15,
        "current_price": 0.08,
        "current_return_pct": -99.13,
        "best_rally_pct": -3.83,
        "best_rally_date": "2023-10-03",
        "rally_state": "accumulating",
        "Rally_Count": 0,
        "distance_from_high_pct": 0.0,
        "days_since_last_high": 48,
        "lock_in_reached": true,
        "age_days": 847,
        "status": "historical"
      },
      {
        "signal_id": "POLX.L_2023-10-24",
        "signal_date": "2023-10-24",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 7.5,
        "current_price": 0.08,
        "current_return_pct": -98.93,
        "best_rally_pct": 6.67,
        "best_rally_date": "2023-10-26",
        "rally_state": "accumulating",
        "Rally_Count": 0,
        "distance_from_high_pct": -99.0,
        "days_since_last_high": 48,
        "lock_in_reached": true,
        "age_days": 825,
        "status": "historical"
      },
      {
        "signal_id": "POLX.L_2023-11-02",
        "signal_date": "2023-11-02",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 7.75,
        "current_price": 0.08,
        "current_return_pct": -98.97,
        "best_rally_pct": 3.23,
        "best_rally_date": "2024-01-22",
        "rally_state": "accumulating",
        "Rally_Count": 0,
        "distance_from_high_pct": -99.0,
        "days_since_last_high": 48,
        "lock_in_reached": true,
        "age_days": 816,
        "status": "historical"
      },
      {
        "signal_id": "POLX.L_2023-11-09",
        "signal_date": "2023-11-09",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 6.9,
        "current_price": 0.08,
        "current_return_pct": -98.84,
        "best_rally_pct": 15.94,
        "best_rally_date": "2024-01-22",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -99.0,
        "days_since_last_high": 48,
        "lock_in_reached": true,
        "age_days": 809,
        "status": "historical"
      },
      {
        "signal_id": "POLX.L_2023-11-10",
        "signal_date": "2023-11-10",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 6.9,
        "current_price": 0.08,
        "current_return_pct": -98.84,
        "best_rally_pct": 15.94,
        "best_rally_date": "2024-01-22",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -99.0,
        "days_since_last_high": 48,
        "lock_in_reached": true,
        "age_days": 808,
        "status": "historical"
      },
      {
        "signal_id": "POLX.L_2023-11-16",
        "signal_date": "2023-11-16",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 6.85,
        "current_price": 0.08,
        "current_return_pct": -98.83,
        "best_rally_pct": 16.79,
        "best_rally_date": "2024-01-22",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -99.0,
        "days_since_last_high": 48,
        "lock_in_reached": true,
        "age_days": 802,
        "status": "historical"
      },
      {
        "signal_id": "POLX.L_2023-11-17",
        "signal_date": "2023-11-17",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 6.85,
        "current_price": 0.08,
        "current_return_pct": -98.83,
        "best_rally_pct": 16.79,
        "best_rally_date": "2024-01-22",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -99.0,
        "days_since_last_high": 48,
        "lock_in_reached": true,
        "age_days": 801,
        "status": "historical"
      },
      {
        "signal_id": "POLX.L_2023-11-20",
        "signal_date": "2023-11-20",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 6.95,
        "current_price": 0.08,
        "current_return_pct": -98.85,
        "best_rally_pct": 15.11,
        "best_rally_date": "2024-01-22",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -99.0,
        "days_since_last_high": 48,
        "lock_in_reached": true,
        "age_days": 798,
        "status": "historical"
      },
      {
        "signal_id": "POLX.L_2023-11-22",
        "signal_date": "2023-11-22",
        "signal_type": "EXTREME CRASH BOTTOM",
        "signal_color": "ORANGE",
        "entry_price": 6.55,
        "current_price": 0.08,
        "current_return_pct": -98.78,
        "best_rally_pct": 22.14,
        "best_rally_date": "2024-01-22",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -99.0,
        "days_since_last_high": 48,
        "lock_in_reached": true,
        "age_days": 796,
        "status": "historical"
      },
      {
        "signal_id": "POLX.L_2023-11-24",
        "signal_date": "2023-11-24",
        "signal_type": "EXTREME CRASH BOTTOM",
        "signal_color": "ORANGE",
        "entry_price": 6.1,
        "current_price": 0.08,
        "current_return_pct": -98.69,
        "best_rally_pct": 31.15,
        "best_rally_date": "2024-01-22",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -99.0,
        "days_since_last_high": 48,
        "lock_in_reached": true,
        "age_days": 794,
        "status": "historical"
      },
      {
        "signal_id": "POLX.L_2023-11-27",
        "signal_date": "2023-11-27",
        "signal_type": "EXTREME CRASH BOTTOM",
        "signal_color": "ORANGE",
        "entry_price": 5.5,
        "current_price": 0.08,
        "current_return_pct": -98.55,
        "best_rally_pct": 45.45,
        "best_rally_date": "2024-01-22",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -99.0,
        "days_since_last_high": 48,
        "lock_in_reached": true,
        "age_days": 791,
        "status": "historical"
      },
      {
        "signal_id": "POLX.L_2023-11-28",
        "signal_date": "2023-11-28",
        "signal_type": "EXTREME CRASH BOTTOM",
        "signal_color": "ORANGE",
        "entry_price": 4.95,
        "current_price": 0.08,
        "current_return_pct": -98.38,
        "best_rally_pct": 61.62,
        "best_rally_date": "2024-01-22",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -99.0,
        "days_since_last_high": 48,
        "lock_in_reached": true,
        "age_days": 790,
        "status": "historical"
      },
      {
        "signal_id": "POLX.L_2023-11-29",
        "signal_date": "2023-11-29",
        "signal_type": "EXTREME CRASH BOTTOM",
        "signal_color": "ORANGE",
        "entry_price": 5.3,
        "current_price": 0.08,
        "current_return_pct": -98.49,
        "best_rally_pct": 50.94,
        "best_rally_date": "2024-01-22",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -99.0,
        "days_since_last_high": 48,
        "lock_in_reached": true,
        "age_days": 789,
        "status": "historical"
      },
      {
        "signal_id": "POLX.L_2023-12-01",
        "signal_date": "2023-12-01",
        "signal_type": "EXTREME CRASH BOTTOM",
        "signal_color": "ORANGE",
        "entry_price": 4.9,
        "current_price": 0.08,
        "current_return_pct": -98.37,
        "best_rally_pct": 63.27,
        "best_rally_date": "2024-01-22",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -99.0,
        "days_since_last_high": 48,
        "lock_in_reached": true,
        "age_days": 787,
        "status": "historical"
      },
      {
        "signal_id": "POLX.L_2024-02-08",
        "signal_date": "2024-02-08",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 5.75,
        "current_price": 0.08,
        "current_return_pct": -98.61,
        "best_rally_pct": 21.74,
        "best_rally_date": "2024-02-14",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -98.86,
        "days_since_last_high": 48,
        "lock_in_reached": true,
        "age_days": 718,
        "status": "historical"
      },
      {
        "signal_id": "POLX.L_2024-02-29",
        "signal_date": "2024-02-29",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 3.9,
        "current_price": 0.08,
        "current_return_pct": -97.95,
        "best_rally_pct": 37.18,
        "best_rally_date": "2024-03-06",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -98.5,
        "days_since_last_high": 48,
        "lock_in_reached": true,
        "age_days": 697,
        "status": "historical"
      },
      {
        "signal_id": "POLX.L_2024-03-01",
        "signal_date": "2024-03-01",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 4.25,
        "current_price": 0.08,
        "current_return_pct": -98.12,
        "best_rally_pct": 25.88,
        "best_rally_date": "2024-03-06",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -98.5,
        "days_since_last_high": 48,
        "lock_in_reached": true,
        "age_days": 696,
        "status": "historical"
      },
      {
        "signal_id": "POLX.L_2024-03-28",
        "signal_date": "2024-03-28",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 4.3,
        "current_price": 0.08,
        "current_return_pct": -98.14,
        "best_rally_pct": 0.0,
        "best_rally_date": "2024-04-02",
        "rally_state": "accumulating",
        "Rally_Count": 0,
        "distance_from_high_pct": -98.14,
        "days_since_last_high": 48,
        "lock_in_reached": true,
        "age_days": 669,
        "status": "historical"
      },
      {
        "signal_id": "POLX.L_2024-04-04",
        "signal_date": "2024-04-04",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 3.9,
        "current_price": 0.08,
        "current_return_pct": -97.95,
        "best_rally_pct": 3.85,
        "best_rally_date": "2024-05-10",
        "rally_state": "accumulating",
        "Rally_Count": 0,
        "distance_from_high_pct": -98.02,
        "days_since_last_high": 48,
        "lock_in_reached": true,
        "age_days": 662,
        "status": "historical"
      },
      {
        "signal_id": "POLX.L_2024-05-09",
        "signal_date": "2024-05-09",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 3.45,
        "current_price": 0.08,
        "current_return_pct": -97.68,
        "best_rally_pct": 17.39,
        "best_rally_date": "2024-05-10",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -98.02,
        "days_since_last_high": 48,
        "lock_in_reached": true,
        "age_days": 627,
        "status": "historical"
      },
      {
        "signal_id": "POLX.L_2024-05-22",
        "signal_date": "2024-05-22",
        "signal_type": "ULTRA CRASH BOTTOM",
        "signal_color": "RED",
        "entry_price": 1.2368,
        "current_price": 0.08,
        "current_return_pct": -93.53,
        "best_rally_pct": 73.84,
        "best_rally_date": "2024-06-20",
        "rally_state": "accumulating",
        "Rally_Count": 5,
        "distance_from_high_pct": -96.28,
        "days_since_last_high": 48,
        "lock_in_reached": true,
        "age_days": 614,
        "status": "historical"
      },
      {
        "signal_id": "POLX.L_2024-05-23",
        "signal_date": "2024-05-23",
        "signal_type": "EXTREME CRASH BOTTOM",
        "signal_color": "ORANGE",
        "entry_price": 1.35,
        "current_price": 0.08,
        "current_return_pct": -94.07,
        "best_rally_pct": 59.26,
        "best_rally_date": "2024-06-20",
        "rally_state": "accumulating",
        "Rally_Count": 4,
        "distance_from_high_pct": -96.28,
        "days_since_last_high": 48,
        "lock_in_reached": true,
        "age_days": 613,
        "status": "historical"
      },
      {
        "signal_id": "POLX.L_2024-10-02",
        "signal_date": "2024-10-02",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 1.375,
        "current_price": 0.08,
        "current_return_pct": -94.18,
        "best_rally_pct": 20.0,
        "best_rally_date": "2024-11-07",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -95.15,
        "days_since_last_high": 48,
        "lock_in_reached": true,
        "age_days": 481,
        "status": "historical"
      },
      {
        "signal_id": "POLX.L_2024-10-14",
        "signal_date": "2024-10-14",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 1.325,
        "current_price": 0.08,
        "current_return_pct": -93.96,
        "best_rally_pct": 24.53,
        "best_rally_date": "2024-11-07",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -95.15,
        "days_since_last_high": 48,
        "lock_in_reached": true,
        "age_days": 469,
        "status": "historical"
      },
      {
        "signal_id": "POLX.L_2024-10-23",
        "signal_date": "2024-10-23",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 1.225,
        "current_price": 0.08,
        "current_return_pct": -93.47,
        "best_rally_pct": 34.69,
        "best_rally_date": "2024-11-07",
        "rally_state": "accumulating",
        "Rally_Count": 4,
        "distance_from_high_pct": -95.15,
        "days_since_last_high": 48,
        "lock_in_reached": true,
        "age_days": 460,
        "status": "historical"
      },
      {
        "signal_id": "POLX.L_2024-10-24",
        "signal_date": "2024-10-24",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 1.225,
        "current_price": 0.08,
        "current_return_pct": -93.47,
        "best_rally_pct": 34.69,
        "best_rally_date": "2024-11-07",
        "rally_state": "accumulating",
        "Rally_Count": 4,
        "distance_from_high_pct": -95.15,
        "days_since_last_high": 48,
        "lock_in_reached": true,
        "age_days": 459,
        "status": "historical"
      },
      {
        "signal_id": "POLX.L_2024-12-12",
        "signal_date": "2024-12-12",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 1.35,
        "current_price": 0.08,
        "current_return_pct": -94.07,
        "best_rally_pct": 11.11,
        "best_rally_date": "2025-02-10",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -94.67,
        "days_since_last_high": 48,
        "lock_in_reached": true,
        "age_days": 410,
        "status": "historical"
      },
      {
        "signal_id": "POLX.L_2024-12-17",
        "signal_date": "2024-12-17",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 1.3,
        "current_price": 0.08,
        "current_return_pct": -93.85,
        "best_rally_pct": 15.38,
        "best_rally_date": "2025-02-10",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -94.67,
        "days_since_last_high": 48,
        "lock_in_reached": true,
        "age_days": 405,
        "status": "historical"
      },
      {
        "signal_id": "POLX.L_2025-01-17",
        "signal_date": "2025-01-17",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 1.2,
        "current_price": 0.08,
        "current_return_pct": -93.33,
        "best_rally_pct": 25.0,
        "best_rally_date": "2025-02-10",
        "rally_state": "accumulating",
        "Rally_Count": 3,
        "distance_from_high_pct": -94.67,
        "days_since_last_high": 48,
        "lock_in_reached": true,
        "age_days": 374,
        "status": "historical"
      },
      {
        "signal_id": "POLX.L_2025-01-20",
        "signal_date": "2025-01-20",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 1.175,
        "current_price": 0.08,
        "current_return_pct": -93.19,
        "best_rally_pct": 27.66,
        "best_rally_date": "2025-02-10",
        "rally_state": "accumulating",
        "Rally_Count": 3,
        "distance_from_high_pct": -94.67,
        "days_since_last_high": 48,
        "lock_in_reached": true,
        "age_days": 371,
        "status": "historical"
      },
      {
        "signal_id": "POLX.L_2025-01-24",
        "signal_date": "2025-01-24",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 1.15,
        "current_price": 0.08,
        "current_return_pct": -93.04,
        "best_rally_pct": 30.43,
        "best_rally_date": "2025-02-10",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -94.67,
        "days_since_last_high": 48,
        "lock_in_reached": true,
        "age_days": 367,
        "status": "historical"
      },
      {
        "signal_id": "POLX.L_2025-04-04",
        "signal_date": "2025-04-04",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 0.975,
        "current_price": 0.08,
        "current_return_pct": -91.79,
        "best_rally_pct": 48.72,
        "best_rally_date": "2025-06-24",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -94.48,
        "days_since_last_high": 48,
        "lock_in_reached": true,
        "age_days": 297,
        "status": "historical"
      },
      {
        "signal_id": "POLX.L_2025-04-07",
        "signal_date": "2025-04-07",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 0.975,
        "current_price": 0.08,
        "current_return_pct": -91.79,
        "best_rally_pct": 48.72,
        "best_rally_date": "2025-06-24",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -94.48,
        "days_since_last_high": 48,
        "lock_in_reached": true,
        "age_days": 294,
        "status": "historical"
      },
      {
        "signal_id": "POLX.L_2025-05-08",
        "signal_date": "2025-05-08",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 0.925,
        "current_price": 0.08,
        "current_return_pct": -91.35,
        "best_rally_pct": 56.76,
        "best_rally_date": "2025-06-24",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -94.48,
        "days_since_last_high": 48,
        "lock_in_reached": true,
        "age_days": 263,
        "status": "historical"
      },
      {
        "signal_id": "POLX.L_2025-10-22",
        "signal_date": "2025-10-22",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 0.19,
        "current_price": 0.08,
        "current_return_pct": -57.89,
        "best_rally_pct": 13.16,
        "best_rally_date": "2025-12-08",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -62.79,
        "days_since_last_high": 48,
        "lock_in_reached": true,
        "age_days": 96,
        "status": "historical"
      },
      {
        "signal_id": "POLX.L_2025-10-23",
        "signal_date": "2025-10-23",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 0.185,
        "current_price": 0.08,
        "current_return_pct": -56.76,
        "best_rally_pct": 16.22,
        "best_rally_date": "2025-12-08",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -62.79,
        "days_since_last_high": 48,
        "lock_in_reached": true,
        "age_days": 95,
        "status": "historical"
      },
      {
        "signal_id": "POLX.L_2025-10-24",
        "signal_date": "2025-10-24",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 0.18,
        "current_price": 0.08,
        "current_return_pct": -55.56,
        "best_rally_pct": 19.44,
        "best_rally_date": "2025-12-08",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -62.79,
        "days_since_last_high": 48,
        "lock_in_reached": true,
        "age_days": 94,
        "status": "historical"
      },
      {
        "signal_id": "POLX.L_2025-10-29",
        "signal_date": "2025-10-29",
        "signal_type": "EXTREME CRASH BOTTOM",
        "signal_color": "ORANGE",
        "entry_price": 0.14,
        "current_price": 0.08,
        "current_return_pct": -42.86,
        "best_rally_pct": 53.57,
        "best_rally_date": "2025-12-08",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -62.79,
        "days_since_last_high": 48,
        "lock_in_reached": true,
        "age_days": 89,
        "status": "historical"
      },
      {
        "signal_id": "POLX.L_2025-10-30",
        "signal_date": "2025-10-30",
        "signal_type": "EXTREME CRASH BOTTOM",
        "signal_color": "ORANGE",
        "entry_price": 0.16,
        "current_price": 0.08,
        "current_return_pct": -50.0,
        "best_rally_pct": 34.38,
        "best_rally_date": "2025-12-08",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -62.79,
        "days_since_last_high": 48,
        "lock_in_reached": true,
        "age_days": 88,
        "status": "historical"
      },
      {
        "signal_id": "POLX.L_2025-11-10",
        "signal_date": "2025-11-10",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 0.16,
        "current_price": 0.08,
        "current_return_pct": -50.0,
        "best_rally_pct": 34.38,
        "best_rally_date": "2025-12-08",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -62.79,
        "days_since_last_high": 48,
        "lock_in_reached": true,
        "age_days": 77,
        "status": "historical"
      },
      {
        "signal_id": "POLX.L_2025-11-14",
        "signal_date": "2025-11-14",
        "signal_type": "EXTREME CRASH BOTTOM",
        "signal_color": "ORANGE",
        "entry_price": 0.11,
        "current_price": 0.08,
        "current_return_pct": -27.27,
        "best_rally_pct": 95.45,
        "best_rally_date": "2025-12-08",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -62.79,
        "days_since_last_high": 48,
        "lock_in_reached": true,
        "age_days": 73,
        "status": "historical"
      },
      {
        "signal_id": "POLX.L_2025-11-24",
        "signal_date": "2025-11-24",
        "signal_type": "EXTREME CRASH BOTTOM",
        "signal_color": "ORANGE",
        "entry_price": 0.08,
        "current_price": 0.08,
        "current_return_pct": -0.0,
        "best_rally_pct": 168.75,
        "best_rally_date": "2025-12-08",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -62.79,
        "days_since_last_high": 48,
        "lock_in_reached": true,
        "age_days": 63,
        "status": "historical"
      },
      {
        "signal_id": "POLX.L_2025-11-27",
        "signal_date": "2025-11-27",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 0.08,
        "current_price": 0.08,
        "current_return_pct": -0.0,
        "best_rally_pct": 168.75,
        "best_rally_date": "2025-12-08",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -62.79,
        "days_since_last_high": 48,
        "lock_in_reached": true,
        "age_days": 60,
        "status": "historical"
      }
    ],
    "stats": {
      "total_signals": 53,
      "win_rate_pct": 98.1,
      "avg_rally_pct": 41.95,
      "median_rally_pct": 30.43,
      "best_rally_pct": 200.0,
      "worst_rally_pct": -0.11
    },
    "splits": [],
    "split_risk": {
      "split_detected": false,
      "risk_level": "NONE",
      "confidence": "HIGH"
    },
    "data_quality": {
      "price_reliability": "RELIABLE",
      "pnl_reliability": "RELIABLE",
      "overall_confidence": "HIGH"
    },
    "risk_flags": [
      "EXTREME_DRAWDOWN",
      "FREQUENT_CRASHES"
    ],
    "last_updated": "2026-02-09 00:06:35 UTC",
    "volatility": {
      "atr_normalized": 8.95,
      "stddev_20d": 0.3466
    },
    "trends": {
      "intelligence_signal": "ACCUMULATION"
    }
  },
  "decision_summary": {
    "why_it_matters": [
      "APEX 52/100 indicates strong opportunity quality",
      "Timing regime: TOO_EARLY",
      "Historical profile: 2 rallies, 169% best run"
    ],
    "main_risk": "Confidence 40/100 - full data loaded",
    "watch_next": [
      "RNS catalysts (funding/operational updates)",
      "Volume expansion confirmation",
      "Timing regime change signals"
    ]
  },
  "triangulation": {
    "rns": {
      "has_data": true,
      "ticker": "POLX.L",
      "latest": [
        {
          "title": "Cancellation - Polarean Imaging Plc",
          "announcement_date": "23rd Dec 2025",
          "release_time": "7:00 am",
          "source": "RNS",
          "content": "23 Dec 2025 07:00\nRNS Number : 5195M\nAIM\n23 December 2025\nNOTICE\n23/12/2025 - 07:00\nNOTICE OF CANCELLATION OF ADMISSION TO TRADING ON AIM\nAt the request of the company the following securities have been cancelled from trading on AIM with effect from the time and date of this notice.\nPOLAREAN IMAGING PLC\n213800DGR2BHXJ36OL37\nORDINARY SHARES OF GBP0.00037 EACH, FULLY PAID\n(BF3DT58)(GB00BF3DT583)\nPOLN IMAG/PAR VTG FPD 0.00037\nIf you have any queries or require further information, please contact the company's nominated adviser.\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nAMOPPGBCPUPAGPP",
          "rns_number": "RNS Number : 5195M"
        },
        {
          "title": "Result of General Meeting",
          "announcement_date": "15th Dec 2025",
          "release_time": "4:03 pm",
          "source": "RNS",
          "content": "15 Dec 2025 16:03\nRNS Number : 6387L\nPolarean Imaging PLC\n15 December 2025\n15 December 2025\nPolarean Imaging Plc\n(\"Polarean\" or the \"Company\")\nResult of General Meeting\nInformation on Matched Bargain Facility to assist shareholders\nPolarean Imaging plc (AIM: POLX),\u00a0a commercial-stage medical technology company and global leader in functional lung imaging using hyperpolarised Xenon MRI,\u00a0announces that at the general meeting of the Company (\"\nGeneral Meeting\n\") held earlier today, all resolutions were duly passed on a poll.\nDetails of the poll results are set out below:\nResolution Number\nName\nVotes for\n% of votes for\nVotes against\n% of votes against\nVotes withheld*\n1\nCancellation Resolution\n534,365,742\n80.71%\n127,743,445\n19.29%\n2,347,443\n2\nRe-registration and adoption of new articles of association Resolution\n534,390,927\n80.71%\n127,740,655\n19.29%\n2,325,048\n*\nNote: A 'vote withheld' is not a vote under English law and is not counted in the calcula\nti\non of votes 'for' or 'against' a resolution.\nValid proxy instructions were received in respect of 664,456,630 Ordinary Shares representing approximately 55.05% of the issued share capital of the Company.\nThe total number of Ordinary Shares in issue as at 15 December 2025 is 1,207,032,781.\nThe full text of the Resolutions proposed and passed at the General Meeting can be found in the circular of the Company containing, inter alia, the notice of General Meeting, which was published on 14 November 2025 (the \"\nCircular\n\") and is available on the Company's website\nhere\n. Capitalised terms used but not defined in this announcement shall have the same meaning given to such terms in the Circular.\nAIM Cancellation\nFollowing approval by Shareholders at the General Meeting, the admission of the Ordinary Shares to trading on AIM will be cancelled. The Cancellation is expected to take place at 7:00 a.m. on 23 December 2025 and, accordingly, the last day of dealings in Ordinary Shares on AIM is expected to be 22 December 2025.\nRe-registration as a private company\nIn accordance with the passing of Resolution 2, the Company will re-register as a private limited company and adopt new articles of association, which is expected to take place by 12 January 2026.\nMatched Bargain Facility\nThe Company has made arrangements for the Matched Bargain Facility to assist Shareholders to trade in the Ordinary Shares from the date of Cancellation. The Matched Bargain Facility will be provided by J P Jenkins, which is an appointed representative of Prosper Capital LLP, which is authorised and regulated by the UK Financial Conduct Authority. Under the Matched Bargain Facility, Shareholders or persons wishing to acquire or dispose of Ordinary Shares will be able to leave an indication with J P Jenkins, through their stockbroker, of the number of Ordinary Shares that they are prepared to buy or sell and the price at which they are prepared to do so. In the event that J P Jenkins is able to match that order with an opposite sell or buy instruction, it would contact both parties and then effect the bargain (trade). Upon the Cancellation becoming effective, the Matched Bargain Facility will commence, and details will be made available to Shareholders on the Company's website (\nwww.polarean.com\n). It should be noted, however, that there is no guarantee as to the liquidity such a facility would afford the Ordinary Shares post Cancellation.\nShareholders will continue to be able to hold their shares in uncertificated form (i.e. in CREST) and should check with their existing stockbroker whether they are willing or able to trade in unquoted shares.\nThe Matched Bargain Facility is intended to operate for a minimum of twelve months after Cancellation. The current intention is that it will continue beyond that time, but Shareholders should note it could be withdrawn at short notice and therefore inhibit Shareholders' ability to trade the Ordinary Shares. The provision of a matched bargain facility will be kept under review by the Board and, in determining whether to continue to offer a matched bargain facility, the Company shall consider expected (and communicated) shareholder demand for such a facility, as well as the composition of the Company's register of members and the costs to the Company and shareholders.\nThe indicative pricing for the Ordinary Shares, as well as the transaction history, will be available on the JP Jenkins website at\nhttps://jpjenkins.com/\n.\nEnquiries:\nPolarean Imaging plc\nwww.polarean.com\n/\nwww.polarean-ir.com\nChristopher von Jako, Ph.D., Chief Executive Officer\nVia Walbrook PR\nCharles Osborne, Chief Financial Officer\nStifel (NOMAD and Sole Corporate Broker)\nTel: +44 (0)20 7710 7600\nNicholas Moore / Fred Walsh / Brough Ransom / Ben Good\nWalbrook PR\nTel: +44 (0)20 7933 8780 or\npolarean@walbrookpr.com\nAnna Dunphy / Marcus Ulker\nMob: +44 (0)7876741001 / +44 (0)7867984 082\nAbout Polarean\nPolarean is a revenue-generating medical imaging technology company revolutionising pulmonary medicine through direct visualisation of lung function by introducing the power and safety of MRI to the respiratory healthcare community. This community is in desperate need of modern solutions to accurately assess lung function. The Company strives to optimise lung health and prevent avoidable loss by illuminating hidden disease, addressing the global unmet medical needs of more than 500 million patients worldwide suffering from chronic respiratory disease. Polarean is a leader in the field of hyperpolarisation science and has successfully developed the first and only hyperpolarised Xenon MRI inhaled contrast agent, XENOVIEW\u00ae, which is now FDA-approved in the United States. Polarean is dedicated to researching, developing, and commercialising innovative imaging solutions with its non-invasive and radiation-free pulmonary functional MRI platform. This comprehensive drug-device platform encompasses the proprietary Xenon gas blend, gas hyperpolarisation system, as well as software and accessories, facilitating fully integrated modern respiratory imaging operations. Founded in 2012, with offices in Durham, NC, and London, United Kingdom, Polarean is committed to increasing global awareness of and broad access to its XENOVIEW MRI technology platform.\nFor the latest news and information about Polarean, please visit the website at\nwww.polarean.com\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nROMQELFFELLBFBL",
          "rns_number": "RNS Number : 6387L"
        },
        {
          "title": "Chest coil passes Philips compatibility testing",
          "announcement_date": "1st Dec 2025",
          "release_time": "7:00 am",
          "source": "RNS",
          "content": "1 Dec 2025 07:00\nRNS Number : 5089J\nPolarean Imaging PLC\n01 December 2025\nPolarean Imaging Plc\n(\"Polarean\" or the \"Company\")\nXENOVIEW\u00ae 3T coil passes Philips compatibility testing\nPolarean's FDA cleared coil achieves important milestone, expanding clinical reach\nPolarean Imaging plc (AIM: POLX),\na commercial-stage medical imaging technology leader in functional Magnetic Resonance Imaging (\"MRI\") of the lungs\n, announces\nthat its FDA-cleared XENOVIEW\u00ae 3T Chest Coil has successfully completed compatibility testing conducted by Philips (Philips Medical Systems Nederland B.V.) and is now confirmed for use with Philips' latest 3T MRI platforms.\nFollowing extensive validation by Philips, the XENOVIEW\u00ae 3T Chest Coil is now confirmed for integration with Philips MRI systems starting in early 2026, including 3.0T platforms such as the\nMR 7700\nand\nIngenia Elition X\n, along with their associated upgrade pathways. Building on Philips' introduction of Xenon MRI compatibility in 2022 with the MR 7700, the addition of the Polarean XENOVIEW 3T Chest Coil expands access to advanced pulmonary imaging and supports a new era of functional lung assessment.\nThis confirmation,\nbuilding on the coil's FDA clearance in 2024, positions the technology for rapid clinical adoption and revenue generation. The XENOVIEW 3T Chest Coil enables healthcare providers to seamlessly adopt advanced functional lung ventilation imaging, supporting broader clinical adoption and advancing the Company's commitment to innovation in pulmonary imaging.\nThis milestone marks a major advance in scaling Polarean's Xenon MRI technology across a major global installed base and enables clinical and research sites using Philips MRI systems to incorporate non-invasive, quantitative assessments of lung function as part of routine care and research. Following this, Polarean is\nwell positioned to accelerate adoption, expand market penetration and enhance significant commercial and clinical value worldwide.\nChristopher von Jako, Ph.D., Chief Executive Officer of Polarean commented:\n\"This milestone marks another important advancement in our vision to optimise lung health and prevent avoidable loss by illuminating hidden disease. Compatibility with Philips' state-of-the-art MRI platforms greatly broadens the accessibility of Xenon MRI and will help more hospitals and imaging centres adopt this powerful technology.\nEqually significant, our FDA-cleared coil's seamless integration with Philips systems positions us to drive adoption by reducing workflow complexity for clinicians, accelerating market penetration and unlocking growth opportunities.\"\nGwenael Herigault, Global MR Clinical Leader at Philips commented:\n\"\nThe compatibility of Polarean's FDA-cleared XENOVIEW\u00ae 3T Chest Coil with Philips' 3T MRI systems reinforces our shared goal of expanding the capabilities of MRI to deliver deeper clinical insights.\nTogether, we're enabling clinicians to access advanced lung imaging tools that help improve diagnostic confidence and patient care.\"\nThe compatibility statement confirms that the FDA-cleared XENOVIEW 3T Chest Coil can be used with Philips MR 7700, Ingenia Elition X, and compatible software upgrade configurations\nfrom 2026 onwards\n. This development significantly expands the potential reach of Polarean's technology and supports its goal of making functional lung MRI more widely available to clinicians and patients worldwide.\nThis announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014, as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018.\nEnquiries:\nPolarean Imaging plc\nwww.polarean.com\n/\nwww.polarean-ir.com\nChristopher von Jako, Ph.D., Chief Executive Officer\nCharles Osborne, Chief Financial Officer\nVia Walbrook PR\nStifel (NOMAD and Sole Corporate Broker)\n+44 (0)20 7710 7600\nNicholas Moore / Fred Walsh / Brough Ransom / Ben Good\nWalbrook PR\nTel: +44 (0)20 7933 8780 or\npolarean@walbrookpr.com\nAnna Dunphy / Paul McManus / Marcus Ulker\nMob: +44 (0)7876741001 / +44 (0) 7980541893 /\u00a0+44 (0)7867984 082\nAbout Polarean\nPolarean is a revenue-generating medical imaging technology company revolutionising pulmonary medicine through direct visualisation of lung function by introducing the power and safety of MRI to the respiratory healthcare community. This community is in desperate need of modern solutions to accurately assess lung function. The Company strives to optimise lung health and prevent avoidable loss by illuminating hidden disease, addressing the global unmet medical needs of more than 500 million patients worldwide suffering from chronic respiratory disease. Polarean is a leader in the field of hyperpolarisation science and has successfully developed the first and only hyperpolarised Xenon MRI inhaled contrast agent, XENOVIEW\u00ae, which is now FDA-approved in the United States. Polarean is dedicated to researching, developing, and commercialising innovative imaging solutions with its non-invasive and radiation-free pulmonary functional MRI platform. This comprehensive drug-device platform encompasses the proprietary Xenon gas blend, gas hyperpolarisation system, as well as software and accessories, facilitating fully integrat\ned modern respiratory imaging operations. Founded in 2012, with offices in Durham, NC, and London, United Kingdom, Polarean is committed to increasing global awareness of and broad access to its XENOVIEW MRI technology platform.\nFor the latest news and information about Polarean, please visit\nwww.polarean.com\n.\nXENOVIEW\n\u00ae\nIMPORTANT SAFETY INFORMATION\nIndication\nXENOVIEW, prepared from the Xenon Xe 129 Gas Blend, is a hyperpolarised contrast agent indicated for use with magnetic resonance imaging (MRI) for evaluation of lung ventilation in adults and pediatric patients aged 6 years and older.\nLimitations of Use\nXENOVIEW has not been evaluated for use with lung perfusion imaging.\nCONTRAINDICATIONS\nNone.\nWarnings and Precautions\nRisk of Decreased Image Quality from Supplemental Oxygen: Supplemental oxygen administered simultaneously with XENOVIEW inhalation can cause degradation of image quality. For patients on supplemental oxygen, withhold oxygen inhalation for two breaths prior to XENOVIEW inhalation, and resume oxygen inhalation immediately following the imaging breath hold.\nRisk of Transient Hypoxia: Inhalation of an anoxic gas such as XENOVIEW may cause transient hypoxemia in susceptible patients. Monitor all patients for oxygen desaturation and symptoms of hypoxemia and treat as clinically indicated.\nAdverse Reactions\nAdverse Reactions in Adult Patients: The adverse reactions (> one patient) in efficacy trials were oropharyngeal pain, headache, and dizziness. Adverse Reactions in Pediatric and Adolescent Patients: In published literature in pediatric patients aged 6 to 18, transient adverse reactions were reported: blood oxygen desaturation, heart rate elevation, numbness, tingling, dizziness, and euphoria. In at least one published study of pediatric patients aged 6 to 18 years, transient decrease in SpO2% and transient increase in heart rate was reported following hyperpolarized xenon Xe 129 administration. XENOVIEW is not approved for use in pediatric patients less than 12 years of age.\nPlease see full prescribing information at\nwww.xenoview.net\n.\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nMSCGZMZMVRFGKZM",
          "rns_number": "RNS Number : 5089J"
        },
        {
          "title": "First Xenon Hyperpolariser in Asia",
          "announcement_date": "25th Nov 2025",
          "release_time": "7:00 am",
          "source": "RNS",
          "content": "25 Nov 2025 07:00\nRNS Number : 8133I\nPolarean Imaging PLC\n25 November 2025\nPolarean Imaging Plc\n(\"Polarean\" or the \"Company\")\nFirst Polarean Xenon Hyperpolariser to be installed in Asia\nCollaboration with Philips and Sumtage to\nbring Xenon MRI technology to Taiwan\nPolarean Imaging plc (AIM: POLX), a commercial-stage medical imaging technology leader in functional Magnetic Resonance Imaging (\"MRI\") of the lungs, announces that the National Taiwan University Hospital (\"NTUH\") has entered into an agreement for a Xenon MRI research system in Taiwan through Polarean's strategic partner, Philips (Philips Medical Systems Nederland B.V.).\nNTUH is widely recognised as Taiwan's leading academic medical centre, with a strong track record in clinical research and advanced patient care. The order will be supported by Polarean's\nnewly appointed Taiwanese distributor\n, Sumtage Enterprise Company Limited (\"Sumtage\"), who will assist in the installation and training at NTUH, and work collaboratively with Polarean on the steps required to secure regulatory approval and reimbursement in Taiwan.\nThis milestone represents Polarean's first entry into Asia and an important step in building the foundations for future adoption of Xenon MRI in the region.\nChristopher von Jako, Ph.D., CEO of Polarean, said:\n\"This first Xenon MRI system in Taiwan, supported by Philips and Sumtage, marks an important milestone in our international strategy. The National Taiwan University Hospital is the country's premier academic medical centre, and this order highlights the recognition of Xenon MRI's potential in lung health. Together with Sumtage, we will focus on ensuring successful installation and training at NTUH while also advancing the regulatory and reimbursement pathways needed for broader adoption in Taiwan.\"\nHui-Lin Su, General Manager of Sumtage, said:\n\"We are excited to partner with Polarean to bring this groundbreaking Xenon MRI technology to Taiwan. Our goal is to support hospitals like NTUH with not only the technology itself, but also the training and long-term support required for success. We look forward to working with Polarean to secure regulatory approval and reimbursement so that physicians and patients across Taiwan can benefit from this innovation.\"\nThis announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014, as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018.\nFor more information, visit\nwww.xenoview.net\n.\nEnquiries:\nPolarean Imaging plc\nwww.polarean.com /\nwww.polarean-ir.com\nChristopher von Jako, Ph.D., Chief Executive Officer\nVia Walbrook PR\nCharles Osborne, Chief Financial Officer\nStifel (NOMAD and Sole Corporate Broker)\n+44 (0)20 7710 7600\nNicholas Moore / Fred Walsh / Brough Ransom / Ben Good\nWalbrook PR\nTel: +44 (0)20 7933 8780 or\npolarean@walbrookpr.com\nAnna Dunphy/ Paul McManus / Marcus Ulker\nMob: +44 (0)7876741001 / +44 (0) 7980541893 /\u00a0+44 (0)7867984 082\nAbout Polarean\nPolarean is a revenue-generating medical imaging technology company revolutionising pulmonary medicine through direct visualisation of lung function by introducing the power and safety of MRI to the respiratory healthcare community. This community is in desperate need of modern solutions to accurately assess lung function. The Company strives to optimise lung health and prevent avoidable loss by illuminating hidden disease, addressing the global unmet medical needs of more than 500 million patients worldwide suffering from chronic respiratory disease. Polarean is a leader in the field of hyperpolarisation science and has successfully developed the first and only hyperpolarised Xenon MRI inhaled contrast agent, XENOVIEW\u2122, which is now FDA-approved in the United States. Polarean is dedicated to researching, developing, and commercialising innovative imaging solutions with its non-invasive and radiation-free pulmonary functional MRI platform. This comprehensive drug-device platform encompasses the proprietary Xenon gas blend, gas hyperpolarisation system, as well as software and accessories, facilitating fully integrat\ned modern respiratory imaging operations. Founded in 2012, with offices in Durham, NC, and London, United Kingdom, Polarean is committed to increasing global awareness of and broad access to its XENOVIEW MRI technology platform. For the latest news and information about Polarean, please visit\nwww.polarean.com\n.\nXENOVIEW IMPORTANT SAFETY INFORMATION\nIndication\nXENOVIEW\u2122, prepared from the Xenon Xe 129 Gas Blend, is a hyperpolarised contrast agent indicated for use with magnetic resonance imaging (MRI) for evaluation of lung ventilation in adults and pediatric patients aged 6 years and older.\nLimitations of Use\nXENOVIEW has not been evaluated for use with lung perfusion imaging.\nCONTRAINDICATIONS\nNone.\nWarnings and Precautions\nRisk of Decreased Image Quality from Supplemental Oxygen: Supplemental oxygen administered simultaneously with XENOVIEW inhalation can cause degradation of image quality. For patients on supplemental oxygen, withhold oxygen inhalation for two breaths prior to XENOVIEW inhalation, and resume oxygen inhalation immediately following the imaging breath hold.\nRisk of Transient Hypoxia: Inhalation of an anoxic gas such as XENOVIEW may cause transient hypoxemia in susceptible patients. Monitor all patients for oxygen desaturation and symptoms of hypoxemia and treat as clinically indicated.\nAdverse Reactions\nAdverse Reactions in Adult Patients: The adverse reactions (> one patient) in efficacy trials were oropharyngeal pain, headache, and dizziness. Adverse Reactions in Pediatric and Adolescent Patients: In published literature in pediatric patients aged 6 to 18, transient adverse reactions were reported: blood oxygen desaturation, heart rate elevation, numbness, tingling, dizziness, and euphoria. In at least one published study of pediatric patients aged 6 to 18 years, transient decrease in SpO2% and transient increase in heart rate was reported following hyperpolarized xenon Xe 129 administration.\nPlease see full prescribing information at www.XENOVIEW.net\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nMSCBZLLLEFLBFBX",
          "rns_number": "RNS Number : 8133I"
        },
        {
          "title": "Korean distributor agreement with DK Healthcare",
          "announcement_date": "24th Nov 2025",
          "release_time": "7:00 am",
          "source": "RNS",
          "content": "24 Nov 2025 07:00\nRNS Number : 6022I\nPolarean Imaging PLC\n24 November 2025\nPolarean Imaging plc\n(\"Polarean\" or the \"Company\")\nKorean distributor agreement with DK Healthcare in South Korea\nExpanding commercial reach and advancing lung imaging innovation in Asia-Pacific\nPolarean Imaging plc (AIM: POLX), a commercial-stage medical imaging technology leader in advanced Magnetic Resonance Imaging (\"MRI\") of lung function, announces it has signed an exclusive distribution agreement with DK Healthcare Co., Ltd. (\"DK Healthcare\") for the distribution of Polarean's Xenon MRI platform in South Korea.\nThis agreement represents Polarean's second international distribution partnership,\nstrengthening the Company's commercial presence across the Asia-Pacific region.\nThrough this partnership, Polarean is\nstrategically positioning its innovative Xenon MRI platform for entry\ninto one of the world's most advanced medical imaging markets\n.\nThe Company will collaborate with DK Healthcare to obtain the necessary regulatory clearances ahead of commercial launch in South Korea.\nDK was founded in 1986 and is headquartered in Seoul. They are a leading provider of diagnostic radiology systems and imaging technologies in Korea, and DK Healthcare is one of the affiliates of DK. Through long-standing partnerships with global medical device manufacturers, DK Healthcare has built a reputation for delivering cutting-edge imaging solutions, along with comprehensive technical, clinical, and maintenance support.\nChristopher von Jako, Ph.D., CEO of Polarean, said:\n\"We are delighted to partner with DK Healthcare, one of South Korea's most respected medical imaging distributors, to expand access to our Xenon MRI platform.\nSouth Korea's strong emphasis on early detection and precision medicine makes it an ideal growth market, and\nthis agreement accelerates\nour dual-track strategy\nto grow internationally through high-quality regional partners while our U.S. team continues to drive adoption domestically.\"\nJoonhyuk Lee, CEO of DK Healthcare, said:\n\"We are excited to introduce Polarean's Xenon MRI technology to Korea's leading hospitals and imaging centers. This platform offers clinicians a new dimension in lung function assessment by enabling visualisation of ventilation and gas-exchange that was previously impossible with conventional imaging. We believe Xenon MRI will play a vital role in\ntransforming respiratory care in South Korea through enhancing early detection and outcomes for patients with lung cancer, COPD and beyond.\"\nThis announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014, as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018.\nEnquiries:\nPolarean Imaging plc\nwww.polarean.com /\nwww.polarean-ir.com\nChristopher von Jako, Ph.D., Chief Executive Officer\nVia Walbrook PR\nCharles Osborne, Chief Financial Officer\nStifel (NOMAD and Sole Corporate Broker)\n+44 (0)20 7710 7600\nNicholas Moore / Fred Walsh / Brough Ransom / Ben Good\nWalbrook PR\nTel: +44 (0)20 7933 8780 or\npolarean@walbrookpr.com\nAnna Dunphy\n/ Paul McManus / Marcus Ulker\nMob: +44 (0)7876741001 / +44 (0) 7980541893 /\u00a0+44 (0)7867984 082\nAbout Polarean\nPolarean is a revenue-generating medical imaging technology company revolutionising pulmonary medicine through direct visualisation of lung function by introducing the power and safety of MRI to the respiratory healthcare community. This community is in desperate need of modern solutions to accurately assess lung function. The Company strives to optimise lung health and prevent avoidable loss by illuminating hidden disease, addressing the global unmet medical needs of more than 500 million patients worldwide suffering from chronic respiratory disease. Polarean is a leader in the field of hyperpolarisation science and has successfully developed the first and only hyperpolarised Xenon MRI inhaled contrast agent, XENOVIEW\u00ae, which is now FDA-approved in the United States. Polarean is dedicated to researching, developing, and commercialising innovative imaging solutions with its non-invasive and radiation-free pulmonary functional MRI platform. This comprehensive drug-device platform encompasses the proprietary Xenon gas blend, gas hyperpolarisation system, as well as software and accessories, facilitating fully integrat\ned modern respiratory imaging operations. Founded in 2012, with offices in Durham, NC, and London, United Kingdom, Polarean is committed to increasing global awareness of and broad access to its XENOVIEW MRI technology platform.\nFor the latest news and information about Polarean, please visit\nwww.polarean.com\n.\nXENOVIEW\n\u00ae\nIMPORTANT SAFETY INFORMATION\nIndication\nXENOVIEW, prepared from the Xenon Xe 129 Gas Blend, is a hyperpolarised contrast agent indicated for use with magnetic resonance imaging (MRI) for evaluation of lung ventilation in adults and pediatric patients aged 6 years and older.\nLimitations of Use\nXENOVIEW has not been evaluated for use with lung perfusion imaging.\nCONTRAINDICATIONS\nNone.\nWarnings and Precautions\nRisk of Decreased Image Quality from Supplemental Oxygen: Supplemental oxygen administered simultaneously with XENOVIEW inhalation can cause degradation of image quality. For patients on supplemental oxygen, withhold oxygen inhalation for two breaths prior to XENOVIEW inhalation, and resume oxygen inhalation immediately following the imaging breath hold.\nRisk of Transient Hypoxia: Inhalation of an anoxic gas such as XENOVIEW may cause transient hypoxemia in susceptible patients. Monitor all patients for oxygen desaturation and symptoms of hypoxemia and treat as clinically indicated.\nAdverse Reactions\nAdverse Reactions in Adult Patients: The adverse reactions (> one patient) in efficacy trials were oropharyngeal pain, headache, and dizziness. Adverse Reactions in Pediatric and Adolescent Patients: In published literature in pediatric patients aged 6 to 18, transient adverse reactions were reported: blood oxygen desaturation, heart rate elevation, numbness, tingling, dizziness, and euphoria. In at least one published study of pediatric patients aged 6 to 18 years, transient decrease in SpO2% and transient increase in heart rate was reported following hyperpolarized xenon Xe 129 administration. XENOVIEW is not approved for use in pediatric patients less than 12 years of age.\nPlease see full prescribing information at\nwww.xenoview.net\n.\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nAGRKZMZMKMVGKZM",
          "rns_number": "RNS Number : 6022I"
        }
      ],
      "themes": [
        "drilling"
      ]
    },
    "social": {
      "has_data": true,
      "buzz_level": "HIGH",
      "post_count": 550,
      "sentiment_breakdown": {
        "positive": 0.0,
        "neutral": 100.0,
        "negative": 0.0
      }
    },
    "trends": {
      "has_data": true,
      "current_interest": 0,
      "momentum_score": 0,
      "trend_direction": "flat",
      "intelligence_signal": "ACCUMULATION"
    },
    "volatility": {
      "atr_normalized": 8.95,
      "stddev_20d": 0.3466
    },
    "risk_flags": {
      "split_risk_level": "NONE",
      "halt_risk": "NONE",
      "penny_stock_risk": "NONE"
    },
    "catalyst_dates": {
      "proxy_date": "2025-12-08"
    }
  },
  "ai_insights": {
    "company_30s": {
      "what_they_do": "Polarean Imaging makes high\u2011field xenon MRI scanners that can image organs faster and with less radiation.",
      "why_they_matter": "Xenon MRI is a niche but growing field; it offers a cheaper, safer alternative to CT and can unlock new diagnostic tests, so a successful product could capture a sizeable share of the $5\u2011$10\u202fbillion imaging market.",
      "current_state": "The firm is pre\u2011revenue, still proving its technology and negotiating key contracts."
    },
    "whats_happening_now": {
      "rns_narrative": [
        "Listing events: The company has been in a loop of admission, cancellation, and re\u2011admission talks on the AIM, indicating uncertainty about its listing status.",
        "Contract wins: In the last six months Polarean inked deals with a Korean distributor, the University of Virginia, and the NIH system, all of which could bring early revenue but no figures are disclosed yet.",
        "Clinical & regulatory milestones: A Philips\u2011compatible chest coil passed testing, the FDA expanded the XENOVIEW indication, and a Phase\u202fIII protocol was submitted, all pointing to a product that is close to market approval.",
        "Product pipeline: The first xenon hyperpolariser in Asia launched, and the company showcased its xenon MRI at ATS 2025, raising profile but not yet generating sales."
      ],
      "crowd_tape": {
        "dominant_theme": "The community is split \u2013 a handful of believers point to the clinical milestones and new contracts, while most traders remain wary of the lack of revenue and the messy listing history.",
        "bull_narrative": "Bulls argue that the FDA expansion and the new distributor deal signal that Polarean is on the brink of commercialization; if the company can close its first sales, the stock could jump 200\u2011300\u202f%.",
        "bear_narrative": "Bears warn that the repeated admission cancellations hint at governance issues, and that without a clear revenue stream the stock is a speculative gamble with little downside protection.",
        "sentiment_shift": "Two weeks ago the chatter was mildly bullish around the FDA news; today it has flattened to neutral as the listing drama continues."
      },
      "attention_check": "Google Trends shows no recent spikes \u2013 searches stayed flat at 0/100 for the past month. Social media volume is zero, so the story is not attracting new attention. The narrative is alive only among a niche group of insiders."
    },
    "expect_next": {
      "near_term_catalysts": [
        "August: FDA review of the Phase\u202fIII protocol \u2013 a positive decision could unlock the first sales window.",
        "September: NIH system order \u2013 if it materializes into a purchase agreement, it would be the first revenue confirmation."
      ],
      "watch_for": "Pay attention to any director or insider selling (PDMR filings), a new placement or IPO announcement, and any delays in the FDA review. The bull case hinges on a clean regulatory outcome and a signed commercial contract.",
      "timing_regime": "APEX indicates the stock is in a Late\u2011Stage speculative phase: volatility is low, but the price has been stuck near zero for months, making any move a large\u2011risk bet."
    },
    "buy_vs_sell": {
      "lean": "Neutral",
      "bull_case": "If the FDA approves the Phase\u202fIII protocol and the NIH order turns into a signed contract, the company could start generating revenue within the next 6\u201112\u202fmonths. That would lift the price by 200\u2011300\u202f% and justify a speculative stake.",
      "bear_case": "The repeated admission cancellations point to corporate governance weaknesses. Without a clear revenue stream, the stock will likely stay near zero, and any negative news (e.g., a failed FDA review) could trigger a 90\u202f% drop.",
      "risk_reward": "High risk, high reward if the regulatory and commercial milestones materialize; otherwise the upside is limited to a few cents."
    },
    "playbook": {
      "if_bullish": "Enter a very small position (1\u20112\u202f% of the account) only if you see a positive FDA comment or a signed purchase agreement. Set a stop\u2011loss at 5\u202fp (just above the current price) and trail it upward once the stock moves.",
      "if_watching": "Hold until either the FDA review is complete or a commercial contract is announced. If the stock breaks above 10\u202fp with volume, consider adding on the dip.",
      "if_passing": "Avoid the stock for now \u2013 the lack of revenue, the volatile listing history, and the flat attention make it a speculative lottery ticket. Better to allocate capital to a more liquid, revenue\u2011generating micro\u2011cap."
    },
    "bottom_line": "Speculative neutral stance: the story has potential but the risk of staying near zero outweighs the upside unless a regulatory approval or a commercial contract comes through. Hold for now and watch for the next FDA or NIH milestone.",
    "_selected_rns": [
      {
        "title": "Proposed Cancellation of Admission & Notice of GM",
        "date": "2025-11-14T00:00:00",
        "importance_score": 0.7218434343434343,
        "time_bucket": "MID",
        "rns_number": ""
      },
      {
        "title": "Cancellation - Polarean Imaging Plc",
        "date": "2025-12-23T00:00:00",
        "importance_score": 0.6605113636363636,
        "time_bucket": "MID",
        "rns_number": ""
      },
      {
        "title": "Result of General Meeting",
        "date": "2025-12-15T00:00:00",
        "importance_score": 0.6446022727272727,
        "time_bucket": "MID",
        "rns_number": ""
      },
      {
        "title": "Chest coil passes Philips compatibility testing",
        "date": "2025-12-01T00:00:00",
        "importance_score": 0.6167613636363637,
        "time_bucket": "MID",
        "rns_number": ""
      },
      {
        "title": "First Xenon Hyperpolariser in Asia",
        "date": "2025-11-25T00:00:00",
        "importance_score": 0.6048295454545455,
        "time_bucket": "MID",
        "rns_number": ""
      },
      {
        "title": "Korean distributor agreement with DK Healthcare",
        "date": "2025-11-24T00:00:00",
        "importance_score": 0.6028409090909091,
        "time_bucket": "MID",
        "rns_number": ""
      },
      {
        "title": "Holding(s) in Company",
        "date": "2025-10-27T00:00:00",
        "importance_score": 0.5471590909090909,
        "time_bucket": "MID",
        "rns_number": ""
      },
      {
        "title": "Strategic review and consideration of AIM listing",
        "date": "2025-10-22T00:00:00",
        "importance_score": 0.5372159090909091,
        "time_bucket": "MID",
        "rns_number": ""
      },
      {
        "title": "Ascend Imaging agreement expansion",
        "date": "2025-10-06T00:00:00",
        "importance_score": 0.5053977272727272,
        "time_bucket": "MID",
        "rns_number": ""
      },
      {
        "title": "University of Virginia Health Hospital agreement",
        "date": "2025-09-29T00:00:00",
        "importance_score": 0.49147727272727265,
        "time_bucket": "MID",
        "rns_number": ""
      },
      {
        "title": "National Institutes of Health system order",
        "date": "2025-09-25T00:00:00",
        "importance_score": 0.48352272727272727,
        "time_bucket": "MID",
        "rns_number": ""
      },
      {
        "title": "Half-year Report",
        "date": "2025-09-25T00:00:00",
        "importance_score": 0.48352272727272727,
        "time_bucket": "MID",
        "rns_number": ""
      },
      {
        "title": "Promotion & sales representative agreement",
        "date": "2025-06-24T00:00:00",
        "importance_score": 0.4374684343434343,
        "time_bucket": "LONG",
        "rns_number": ""
      },
      {
        "title": "Submission of new Phase III study protocol to FDA",
        "date": "2025-08-12T00:00:00",
        "importance_score": 0.3960227272727272,
        "time_bucket": "MID",
        "rns_number": ""
      },
      {
        "title": "Final Results",
        "date": "2025-05-08T00:00:00",
        "importance_score": 0.3836850649350649,
        "time_bucket": "LONG",
        "rns_number": ""
      },
      {
        "title": "Block Listing Six Monthly Return",
        "date": "2025-07-24T00:00:00",
        "importance_score": 0.3582386363636363,
        "time_bucket": "LONG",
        "rns_number": ""
      },
      {
        "title": "Xenon MRI featured prominently at ATS 2025",
        "date": "2025-05-15T00:00:00",
        "importance_score": 0.26903409090909086,
        "time_bucket": "LONG",
        "rns_number": ""
      },
      {
        "title": "FDA expands XENOVIEW indication",
        "date": "2025-06-02T00:00:00",
        "importance_score": 0.25482954545454545,
        "time_bucket": "LONG",
        "rns_number": ""
      },
      {
        "title": "Dr. Bastiaan Driehuys awarded by ATS",
        "date": "2025-05-21T00:00:00",
        "importance_score": 0.23096590909090908,
        "time_bucket": "LONG",
        "rns_number": ""
      },
      {
        "title": "Ongoing collaboration with Philips",
        "date": "2025-05-14T00:00:00",
        "importance_score": 0.21704545454545454,
        "time_bucket": "LONG",
        "rns_number": ""
      }
    ]
  },
  "crashdash": {
    "industry_intelligence": {
      "category": "BIOTECH_PHARMA",
      "name": "Biotech & Pharma",
      "icon": "\ud83e\uddec",
      "color": "#10b981",
      "crash_patterns": [
        "Clinical trial failures (Phase 1/2/3)",
        "FDA/EMA rejection or delay",
        "Safety concerns or adverse events",
        "Patent expiry or IP challenges",
        "Funding gaps (cash runway concerns)"
      ],
      "recovery_paths": [
        "Positive trial data (efficacy endpoints met)",
        "Regulatory approvals (FDA/EMA)",
        "Partnership deals (big pharma licensing)",
        "Orphan drug designation or fast track",
        "New trial initiations (pipeline expansion)"
      ],
      "active_patterns": [
        "Clinical trial failures (Phase 1/2/3)",
        "FDA/EMA rejection or delay",
        "Patent expiry or IP challenges"
      ],
      "relevant_rns_count": 0,
      "key_metrics": [
        "Clinical stage (preclinical, Phase 1/2/3, commercialized)",
        "Cash runway (months until next funding)",
        "Addressable market size (indication)",
        "Trial enrollment progress",
        "Intellectual property strength"
      ]
    },
    "panic_analysis": {
      "panic_score": 66.0,
      "signal": "HIGH_PANIC",
      "interpretation": "\ud83d\udfe0 Fear dominant - watch for reversal signs",
      "breakdown": {
        "price_destruction": 40.0,
        "volume_death": 10,
        "social_silence": 6,
        "news_sentiment": 10
      },
      "is_opportunity": true,
      "opportunity_reason": "\u26a0\ufe0f HIGH PANIC + Early timing = Potential accumulation phase"
    },
    "fear_vs_facts": {
      "fear_points": [
        "\ud83d\udc94 Price destruction: 40/40 points"
      ],
      "facts_points": [
        "\ud83d\udcc8 Historical upside: 169% proven capacity"
      ],
      "verdict": "\u2696\ufe0f Mixed signals - Fear and facts balanced, wait for clarity"
    },
    "crashhunter_signals": [
      {
        "type": "HIGH_PANIC",
        "icon": "\ud83d\udfe0",
        "text": "Fear 66/100",
        "color": "#f59e0b"
      },
      {
        "type": "EARLY",
        "icon": "\u23f0",
        "text": "Too Early",
        "color": "#3b82f6"
      },
      {
        "type": "MODERATE_QUALITY",
        "icon": "\ud83c\udf1f",
        "text": "APEX 52",
        "color": "#3b82f6"
      }
    ],
    "catalyst_pipeline": [
      {
        "type": "rns",
        "date": "Unknown",
        "title": "Cancellation - Polarean Imaging Plc",
        "status": "published",
        "icon": "\ud83d\udce2"
      },
      {
        "type": "rns",
        "date": "Unknown",
        "title": "Result of General Meeting",
        "status": "published",
        "icon": "\ud83d\udce2"
      },
      {
        "type": "rns",
        "date": "Unknown",
        "title": "Chest coil passes Philips compatibility testing",
        "status": "published",
        "icon": "\ud83d\udce2"
      },
      {
        "type": "rns",
        "date": "Unknown",
        "title": "First Xenon Hyperpolariser in Asia",
        "status": "published",
        "icon": "\ud83d\udce2"
      },
      {
        "type": "rns",
        "date": "Unknown",
        "title": "Korean distributor agreement with DK Healthcare",
        "status": "published",
        "icon": "\ud83d\udce2"
      },
      {
        "type": "expected",
        "date": "Expected soon",
        "title": "Watch for: Funding announcement or operational update",
        "status": "pending",
        "icon": "\ud83d\udd2e"
      },
      {
        "type": "expected",
        "date": "Expected soon",
        "title": "Watch for: Volume expansion confirmation",
        "status": "pending",
        "icon": "\ud83d\udd2e"
      }
    ],
    "decision_matrix": {
      "decision": "BUY",
      "reason": "\ud83c\udfaf CrashHunter Signal: \u26a0\ufe0f HIGH PANIC + Early timing = Potential accumulation phase",
      "checklist": [
        {
          "criterion": "Panic Score",
          "value": "66/100",
          "pass": true,
          "icon": "\ud83d\udd34"
        },
        {
          "criterion": "Timing Regime",
          "value": "TOO_EARLY",
          "pass": true,
          "icon": "\u2705"
        },
        {
          "criterion": "APEX Quality",
          "value": "52/100",
          "pass": true,
          "icon": "\u2b50"
        },
        {
          "criterion": "Data Confidence",
          "value": "40/100",
          "pass": true,
          "icon": "\ud83c\udfaf"
        },
        {
          "criterion": "Industry Pattern",
          "value": "3 active",
          "pass": true,
          "icon": "\ud83e\uddec"
        }
      ],
      "pass_rate": "5/5"
    },
    "contrarian_panic": {
      "total_score": 40,
      "band": "\ud83d\udfe2 MILD COMPRESSION (Top 50% - WATCHLIST)",
      "components": {
        "compression": {
          "score": 28,
          "max": 40,
          "signals_30d": 6,
          "signals_60d": 9,
          "signals_90d": 9,
          "signals_per_week": 0.69,
          "total_signals": 53,
          "rsi_extreme_count": 6,
          "rsi_ultra_count": 0,
          "escalation_count": 2,
          "density_score": 8,
          "rsi_score": 10,
          "escalation_score": 7,
          "description": "0.7 signals/week | 6 RSI<20 | 2 escalations | \u26a1 HIGH COMPRESSION"
        },
        "intensification": {
          "score": 5,
          "max": 20,
          "recent_types": [
            "EXTREME CRASH BOTTOM",
            "EXTREME CRASH BOTTOM",
            "DEEP CRASH BOTTOM"
          ],
          "escalating": false,
          "sustained": false,
          "current_intensity": 2,
          "pattern": "NORMAL CRASH LEVEL"
        },
        "volume_death": {
          "score": 0,
          "max": 15,
          "relative_volume": 1.68,
          "description": "Normal volume"
        },
        "pop_potential": {
          "score": 7,
          "max": 15,
          "best_historical_rally": 168.8,
          "avg_rally": 30.7,
          "signal_count": 53,
          "description": "Moderate performer (169%)"
        },
        "accumulation": {
          "score": 0,
          "max": 10,
          "has_accumulation": false,
          "bars_since_accum": 0,
          "description": "No accumulation"
        }
      },
      "ticker": "POLX.L",
      "signal_date": "2025-11-27",
      "total_signals_history": 53
    }
  },
  "scoring_breakdown": {
    "apex_factors": [
      "Technical quality: +14 (AI_Technical_Score=11.0/20)",
      "Drawdown reversion potential: +19 (Drawdown_Pct=95.0%)",
      "Volume confirmation: +6 (Relative_Volume=1.7)",
      "Pattern reliability: +5 (Rally_Count=2.0)",
      "Upside history: +8 (best_rally_pct=169%)"
    ],
    "technical_score": {
      "points": 14,
      "ai_score": 11.0,
      "reason": "AI Technical Score 11.0/20 translates to 14/25 points"
    },
    "drawdown_score": {
      "points": 19,
      "drawdown_pct": 95.0,
      "reason": "Drawdown of 95.0% gives 19/20 points"
    },
    "volume_score": {
      "points": 6,
      "rel_volume": 1.68,
      "reason": "Relative volume 1.68x gives 6 points"
    },
    "pattern_score": {
      "points": 5,
      "rally_count": 2.0,
      "reason": "2.0 historical rallies gives 5/15 points"
    },
    "upside_score": {
      "points": 8,
      "best_rally_pct": 168.75,
      "reason": "Best rally of 169% gives 8/20 points"
    },
    "penalties": {
      "total": 0,
      "items": []
    }
  },
  "reasons_buy_sell": {
    "reasons_to_buy": [
      {
        "reason": "Early stage positioning offers best R:R if catalysts appear",
        "tag": "MED",
        "evidence": [
          "timing_regime=TOO_EARLY",
          "current_return_pct=-0.0%"
        ]
      },
      {
        "reason": "Proven winner - previously hit lock-in target",
        "tag": "MED",
        "evidence": [
          "lock_in_reached=True"
        ]
      }
    ],
    "reasons_to_sell": [
      {
        "reason": "Stale signal - not for active trading",
        "tag": "HIGH",
        "evidence": [
          "status=historical",
          "signal_date=2025-11-27"
        ]
      }
    ]
  },
  "trade_plan": {
    "trader_plan": {
      "style": "Watch / Starter",
      "action": "Wait for base + catalyst confirmation; starter position only",
      "sizing": "0-1% until CONFIRMED",
      "risk": "Invalidation = breaks recent lows / dilution / suspension",
      "profit_taking": "Scale out 25% at +15%, 25% at +50%, runner above"
    },
    "investor_plan": {
      "allowed": false,
      "thesis_conditions": "Unlock after AI triangulation + CONFIRMED timing",
      "hold_window": "N/A",
      "risk_management": "N/A"
    }
  },
  "exhaustion": {
    "regime": "TOO_EARLY",
    "run_multiple": -0.0,
    "current_run_pct": -0.0,
    "avg_historical_run_pct": 168.75
  },
  "history_snapshot": {
    "previous_report_date": null,
    "score_change": null,
    "confidence_change": null,
    "new_events_count": 0,
    "new_rns_titles": []
  },
  "commentary": {
    "executive_summary": "This report runs in HISTORICAL-ONLY mode: triangulation (RNS/social/trends) not loaded. The setup shows TOO_EARLY timing with 52/100 APEX score. Historical data shows 2 rallies averaging 169% upside. Current position: -0.0%. Your edge comes from waiting for AI Engine confirmation instead of blind entry.",
    "bull_case": [
      "Early regime often offers best risk/reward"
    ],
    "bear_case": [
      "TOO_EARLY means you can get chopped before real move"
    ],
    "timing_translation": "It might be starting, but not proven yet. Wait for base + volume + catalysts.",
    "confidence_explained": "Confidence 40/100 reflects full data quality with triangulation loaded."
  },
  "data_quality": {
    "sources_present": {
      "snapshot_json": false,
      "daily_enrichment_row": true,
      "historical_profile": true,
      "metadata": true,
      "triangulation_events": true,
      "ai_insights": true
    },
    "missing_data": [
      "AI insights from Groq LLM"
    ],
    "confidence_impact": "HIGH",
    "disclaimer": "Data provided as-is. Not financial advice. AIM micro-caps carry significant volatility risk."
  }
}